SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-000039
Filing Date
2022-01-03
Accepted
2022-01-03 07:38:58
Documents
14
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49093
2 ex99-1.htm EX-99.1 14127
3 ex99-1_001.jpg GRAPHIC 3501
  Complete submission text file 0001493152-22-000039.txt   248530

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE indp-20220103.xsd EX-101.SCH 3039
5 XBRL LABEL FILE indp-20220103_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE indp-20220103_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3540
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 22500400
SIC: 2834 Pharmaceutical Preparations